Annual Total Debt
$0.00
$0.000.00%
30 April 2024
Summary:
PharmaCyte Biotech annual total debt is currently $0.00, unchanged on 30 April 2024. During the last 3 years, it has risen by $0.00 (0.00%). PMCB annual total debt is now -100.00% below its all-time high of $2.48 million, reached on 30 April 2009.PMCB Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$0.00
$0.000.00%
31 July 2024
Summary:
PharmaCyte Biotech quarterly total debt is currently $0.00, unchanged on 31 July 2024. Over the past year, it has stayed the same.PMCB quarterly total debt is now -100.00% below its all-time high of $2.97 million, reached on 31 July 2004.PMCB Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Total Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | 0.0% | 0.0% |
3 y3 years | 0.0% | 0.0% |
5 y5 years | 0.0% | 0.0% |
PMCB Total Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | -100.0% | -100.0% | ||
alltime | all time | -100.0% | -100.0% |
PharmaCyte Biotech Total Debt History
Date | Annual | Quarterly |
---|---|---|
July 2024 | - | $0.00(0.0%) |
Apr 2024 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2024 | - | $0.00(0.0%) |
Oct 2023 | - | $0.00(0.0%) |
July 2023 | - | $0.00(0.0%) |
Apr 2023 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2023 | - | $0.00(0.0%) |
Oct 2022 | - | $0.00(0.0%) |
July 2022 | - | $0.00(0.0%) |
Apr 2022 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2022 | - | $0.00(0.0%) |
Oct 2021 | - | $0.00(0.0%) |
July 2021 | - | $0.00(0.0%) |
Apr 2021 | $0.00(-100.0%) | $0.00(-100.0%) |
Jan 2021 | - | $75.20 K(0.0%) |
Oct 2020 | - | $75.20 K(0.0%) |
July 2020 | - | $75.20 K(0.0%) |
Apr 2020 | $75.20 K(>+9900.0%) | $75.20 K(>+9900.0%) |
Jan 2020 | - | $0.00(0.0%) |
Oct 2019 | - | $0.00(0.0%) |
July 2019 | - | $0.00(0.0%) |
Apr 2019 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2019 | - | $0.00(0.0%) |
Oct 2018 | - | $0.00(0.0%) |
July 2018 | - | $0.00(0.0%) |
Apr 2018 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2018 | - | $0.00(0.0%) |
Oct 2017 | - | $0.00(0.0%) |
July 2017 | - | $0.00(0.0%) |
Apr 2017 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2017 | - | $0.00(0.0%) |
Oct 2016 | - | $0.00(0.0%) |
July 2016 | - | $0.00(0.0%) |
Apr 2016 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2016 | - | $0.00(0.0%) |
Oct 2015 | - | $0.00(0.0%) |
July 2015 | - | $0.00(0.0%) |
Apr 2015 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2015 | - | $0.00(0.0%) |
Oct 2014 | - | $0.00(0.0%) |
July 2014 | - | $0.00(0.0%) |
Apr 2014 | $0.00 | $0.00(-100.0%) |
Jan 2014 | - | $20.00 K(-95.2%) |
Oct 2013 | - | $420.00 K(0.0%) |
Date | Annual | Quarterly |
---|---|---|
July 2013 | - | $420.00 K(0.0%) |
Apr 2013 | $420.00 K(-79.9%) | $420.00 K(-41.0%) |
Jan 2013 | - | $712.00 K(+69.5%) |
Oct 2012 | - | $420.00 K(-42.5%) |
July 2012 | - | $730.00 K(-65.1%) |
Apr 2012 | $2.09 M(-11.8%) | $2.09 M(-15.0%) |
Jan 2012 | - | $2.46 M(+4.0%) |
Oct 2011 | - | $2.37 M(-0.1%) |
July 2011 | - | $2.37 M(-0.1%) |
Apr 2011 | $2.37 M(-0.5%) | $2.37 M(-0.1%) |
Jan 2011 | - | $2.37 M(-0.1%) |
Oct 2010 | - | $2.38 M(-0.1%) |
July 2010 | - | $2.38 M(-0.1%) |
Apr 2010 | $2.38 M(-3.9%) | $2.38 M(+1.6%) |
Jan 2010 | - | $2.34 M(-1.0%) |
Oct 2009 | - | $2.37 M(-0.8%) |
July 2009 | - | $2.39 M(-3.7%) |
Apr 2009 | $2.48 M(>+9900.0%) | $2.48 M(>+9900.0%) |
Jan 2009 | - | $0.00(0.0%) |
Oct 2008 | - | $0.00(0.0%) |
July 2008 | - | $0.00(0.0%) |
Apr 2008 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2008 | - | $0.00(0.0%) |
Oct 2007 | - | $0.00(0.0%) |
July 2007 | - | $0.00(0.0%) |
Apr 2007 | $0.00(-100.0%) | $0.00(-100.0%) |
Jan 2007 | - | $457.90 K(-2.1%) |
Oct 2006 | - | $467.90 K(-2.1%) |
July 2006 | - | $477.90 K(-5.9%) |
Apr 2006 | $508.00 K(-60.3%) | $508.00 K(-56.9%) |
Jan 2006 | - | $1.18 M(-15.3%) |
Oct 2005 | - | $1.39 M(-2.6%) |
July 2005 | - | $1.43 M(+11.7%) |
Apr 2005 | $1.28 M(+293.2%) | $1.28 M(-57.0%) |
Jan 2005 | - | $2.97 M(0.0%) |
Oct 2004 | - | $2.97 M(0.0%) |
July 2004 | - | $2.97 M(+813.7%) |
Apr 2004 | $325.00 K(>+9900.0%) | $325.00 K(+261.1%) |
Jan 2004 | - | $90.00 K(>+9900.0%) |
Oct 2003 | - | $0.00(0.0%) |
July 2003 | - | $0.00(0.0%) |
Apr 2003 | $0.00(0.0%) | $0.00(0.0%) |
Jan 2003 | - | $0.00 |
Apr 2002 | $0.00 | - |
FAQ
- What is PharmaCyte Biotech annual total debt?
- What is the all time high annual total debt for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual total debt year-on-year change?
- What is PharmaCyte Biotech quarterly total debt?
- What is the all time high quarterly total debt for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly total debt year-on-year change?
What is PharmaCyte Biotech annual total debt?
The current annual total debt of PMCB is $0.00
What is the all time high annual total debt for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual total debt is $2.48 M
What is PharmaCyte Biotech annual total debt year-on-year change?
Over the past year, PMCB annual total debt has changed by $0.00 (0.00%)
What is PharmaCyte Biotech quarterly total debt?
The current quarterly total debt of PMCB is $0.00
What is the all time high quarterly total debt for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly total debt is $2.97 M
What is PharmaCyte Biotech quarterly total debt year-on-year change?
Over the past year, PMCB quarterly total debt has changed by $0.00 (0.00%)